pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 17·1 min read
save

MDCalc introduces quality-rating system for over 800 clinical calculators used by doctors

Jul 17, 2026·read at STAT ↗Positive

MDCalc, a health‑technology company, announced a new quality‑rating system that will evaluate the more than 800 clinical calculators doctors rely on for decisions such as kidney function, birth outcomes, and disease risk.

The ratings are intended to increase accountability and equity by highlighting the validation strength and limitations of each tool, addressing concerns that many calculators lack robust evidence.

The initiative, led by health‑systems researcher Shazia Siddique who joined MDCalc last year, aims to help clinicians choose reliable scores and improve patient care across specialties.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: MDCalc is scoring the clinical calculators used by millions of doctors”

read at STAT ↗
519 words · retrieved Jul 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Nephrology2Gene Therapy (AAV)Psychiatry & CNSType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 1d agoBeyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical modelsBioSpace
  • Jul 30Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemptionSTAT
  • Jul 24Amgen deploys patients to defend troubled Tavneos in FDA hearing requestBioSpace
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT